For discussion: live attenuated vaccines for group B meningococcus

Author： Tang C.   Moxon R.   Levine M.M.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.17, Iss.2, 1999-01, pp. : 114-117

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Live attenuated vaccines against influenza; an historical review

By Wareing M.D.   Tannock G.A.  

Vaccine, Vol. 19, Iss. 25, 2001-05 ,pp. : 3320-3330

Elsevier

Access to resources Recommend Favorite

Cold-attenuated live influenza vaccines, a risk-benefit assessment

By Pfleiderer M.   Lower J.   Kurth R.  

Vaccine, Vol. 20, Iss. 5, 2001-12 ,pp. : 886-894

Elsevier

Access to resources Recommend Favorite

Live attenuated influenza virus vaccines: new options for the prevention of influenza

By Nichol K.L.  

Vaccine, Vol. 19, Iss. 31, 2001-08 ,pp. : 4373-4377

Elsevier

Access to resources Recommend Favorite

Animal models paving the way for clinical trials of attenuated Salmonella enterica serovar Typhi live oral vaccines and live vectors

By Pasetti M.F.   Levine M.M.   Sztein M.B.  

Vaccine, Vol. 21, Iss. 5, 2003-01 ,pp. : 401-418

Elsevier

Access to resources Recommend Favorite

Passive immunization with Neisseria meningitidis PorA specific immune sera reduces nasopharyngeal colonization of group B meningococcus in an infant rat nasal challenge model

By Schmidt S.   Zhu D.   Barniak V.   Mason K.   Zhang Y.   Arumugham R.   Metcalf T.  

Vaccine, Vol. 19, Iss. 32, 2001-09 ,pp. : 4851-4858

Elsevier

Access to resources Recommend Favorite